
Adverum Biotechnologies is a biotechnology business based in the US. Adverum Biotechnologies shares (ADVM) are listed on the NASDAQ and all prices are listed in US Dollars. Adverum Biotechnologies employs 188 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Adverum Biotechnologies stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ADVM. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Adverum Biotechnologies stock price (NASDAQ: ADVM)
Use our graph to track the performance of ADVM stocks over time.Adverum Biotechnologies shares at a glance
Latest market close | $0.69 |
---|---|
52-week range | $0.53 - $1.82 |
50-day moving average | $0.65 |
200-day moving average | $1.01 |
Wall St. target price | $3.67 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.58 |
Buy Adverum Biotechnologies stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Adverum Biotechnologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adverum Biotechnologies price performance over time
Historical closes compared with the close of $0.694 from 2023-01-27
1 week (2023-01-23) | 6.77% |
---|---|
1 month (2022-12-30) | 19.66% |
3 months (2022-10-28) | -23.32% |
6 months (2022-07-29) | -52.47% |
1 year (2022-01-27) | -53.73% |
---|---|
2 years (2021-01-29) | -94.37% |
3 years (2020-01-30) | 10.39 |
5 years (2018-01-30) | 7.95 |
Adverum Biotechnologies financials
Gross profit TTM | $-81,681,000 |
---|---|
Return on assets TTM | -22.93% |
Return on equity TTM | -56.36% |
Profit margin | 0% |
Book value | $2.09 |
Market capitalisation | $66.8 million |
TTM: trailing 12 months
Adverum Biotechnologies share dividends
We're not expecting Adverum Biotechnologies to pay a dividend over the next 12 months.
Adverum Biotechnologies share price volatility
Over the last 12 months, Adverum Biotechnologies's shares have ranged in value from as little as $0.531 up to $1.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adverum Biotechnologies's is 0.7548. This would suggest that Adverum Biotechnologies's shares are less volatile than average (for this exchange).
Adverum Biotechnologies overview
Adverum Biotechnologies, Inc. , a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc.
Adverum Biotechnologies in the news
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Frequently asked questions
What percentage of Adverum Biotechnologies is owned by insiders or institutions?Currently 3.672% of Adverum Biotechnologies shares are held by insiders and 62.781% by institutions. How many people work for Adverum Biotechnologies?
Latest data suggests 188 work at Adverum Biotechnologies. When does the fiscal year end for Adverum Biotechnologies?
Adverum Biotechnologies's fiscal year ends in December. Where is Adverum Biotechnologies based?
Adverum Biotechnologies's address is: 800 Saginaw Drive, Redwood City, CA, United States, 94063 What is Adverum Biotechnologies's ISIN number?
Adverum Biotechnologies's international securities identification number is: US00773U1088 What is Adverum Biotechnologies's CUSIP number?
Adverum Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 05337G107
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert